ES2111581T3 - Disoluciones estabilizadas de pvp-i. - Google Patents

Disoluciones estabilizadas de pvp-i.

Info

Publication number
ES2111581T3
ES2111581T3 ES92106500T ES92106500T ES2111581T3 ES 2111581 T3 ES2111581 T3 ES 2111581T3 ES 92106500 T ES92106500 T ES 92106500T ES 92106500 T ES92106500 T ES 92106500T ES 2111581 T3 ES2111581 T3 ES 2111581T3
Authority
ES
Spain
Prior art keywords
solution
pvp
dissolutions
stabilized
microbicidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92106500T
Other languages
English (en)
Inventor
Dileep Bhagwat
Benjamin Oshlack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2111581T3 publication Critical patent/ES2111581T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)

Abstract

SE DESCRIBEN SOLUCIONES DE POVIDONA-YODO (PVP-I) ESTABLES SEGUN LAS NORMAS U.S.P. Y UN METODO PARA PREPARARLAS. LA SOLUCION PVP-I INCLUYE UNA CANTIDAD EFICAZ MICROBICIDAL DE YODO DISPONIBLE Y UN AGENTE ALCALINIZANTE EN UNA CANTIDAD EFICAZ PARA MANTENER LA ESTABILIDAD DE LA SOLUCION SEGUN LAS NORMAS U.S.P. CUANDO SE ALMACENA DICHA SOLUCION EN UN CONTENEDOR DE CRISTAL, LA SOLUCION NO SE TAMPONA. EN REALIZACIONES PREFERIDAS, LA SOLUCION YODOFORA ES UNA SOLUCION PVP-I MICROBICIDAL PARA USO OFTALMICO.
ES92106500T 1991-07-16 1992-04-15 Disoluciones estabilizadas de pvp-i. Expired - Lifetime ES2111581T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/730,462 US5126127A (en) 1991-07-16 1991-07-16 Stabilized PVP-I solutions

Publications (1)

Publication Number Publication Date
ES2111581T3 true ES2111581T3 (es) 1998-03-16

Family

ID=24935466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92106500T Expired - Lifetime ES2111581T3 (es) 1991-07-16 1992-04-15 Disoluciones estabilizadas de pvp-i.

Country Status (16)

Country Link
US (1) US5126127A (es)
EP (1) EP0526695B1 (es)
JP (1) JP3531945B2 (es)
KR (1) KR100191873B1 (es)
AT (1) ATE163130T1 (es)
AU (1) AU646745B2 (es)
CA (1) CA2062001C (es)
DE (1) DE69224416T2 (es)
DK (1) DK0526695T3 (es)
EG (1) EG19995A (es)
ES (1) ES2111581T3 (es)
FI (1) FI114443B (es)
IE (1) IE920796A1 (es)
IL (1) IL101079A (es)
NO (1) NO306379B1 (es)
ZA (1) ZA921365B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2685892A (en) * 1991-10-08 1993-05-03 Isp Investments Inc. Method of treating blood
GB9306296D0 (en) * 1993-03-26 1993-05-19 Diversey Corp Improved iodophors,production and use thereof
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
JP3108262B2 (ja) * 1993-12-22 2000-11-13 明治製菓株式会社 研磨剤を含有しない口腔用半練状製剤
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
EP1479379B1 (en) 2003-05-19 2007-08-29 Euro-Celtique S.A. Dry liposomal PVP-iodine compositions
US20050262811A1 (en) * 2004-05-27 2005-12-01 Mahmood Mohiuddin Sterilization process for iodine-containing antimicrobial topical solutions
AU2016253668B2 (en) * 2006-03-14 2018-12-06 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
AU2013203462B2 (en) * 2006-03-14 2016-08-04 Cls Pharmaceuticals, Inc. Ophthalmic compositions comprising povidone-iodine
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
JP5083502B2 (ja) * 2006-12-25 2012-11-28 ライオン株式会社 眼科用組成物
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
EP3777536A1 (en) * 2008-06-12 2021-02-17 Takeda Pharmaceutical Company Limited Povidone iodine, a novel alternative preservative for ophthalmic compositions
TWI618539B (zh) * 2009-12-15 2018-03-21 遠景生物製藥股份有限公司 無刺激性眼用聚乙烯吡咯啶酮-碘組成物
JP5367597B2 (ja) 2010-01-18 2013-12-11 株式会社オフテクス コンタクトレンズ洗浄用有核錠及びそれを含むコンタクトレンズ洗浄用製剤、並びにコンタクトレンズ洗浄方法
GB201114725D0 (en) 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
CN113679697A (zh) 2012-09-12 2021-11-23 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
DK3181119T3 (da) 2012-09-12 2019-09-16 Novaliq Gmbh Semifluorerede alkansammensætninger til anvendelse ved behandling af keratoconjunctivitis sicca
US20180200289A1 (en) * 2015-07-02 2018-07-19 Veloce Biopharma, Llc Novel ophthalmic composition and methods of use
US9770466B2 (en) 2015-07-02 2017-09-26 Veloce Biopharma, Llc Ophthalmic composition and methods of use
CN108348777B (zh) 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
IT201700068170A1 (it) * 2017-06-20 2018-12-20 Iromed Group S R L Composizione disinfettante per uso oftalmico
WO2019040051A1 (en) * 2017-08-22 2019-02-28 Veloce Biopharma, Llc NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
EP3512522B1 (en) 2017-09-02 2025-11-12 IVIEW Therapeutics, Inc. In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
JP2021522219A (ja) 2018-04-27 2021-08-30 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
KR20200081160A (ko) 2018-12-27 2020-07-07 유한회사 플루켐 염화나트륨 함유 포비돈 요오드 안정 조성물 및 방법
JP2022538711A (ja) 2019-06-10 2022-09-06 ファイアブリック・ファーマ・リミテッド 粘膜へのポビドンヨードの局所適用を使用する高病原性ウイルスによる感染の予防
CN114502205B (zh) * 2019-08-18 2024-08-06 艾威药业公司 含稀聚维酮碘制剂的稳定药品
IL298888A (en) * 2020-06-10 2023-02-01 Firebrick Pharma Ltd Preparations for the treatment of the virus
AU2021203846B2 (en) * 2021-06-10 2022-11-24 Firebrick Pharma Limited Virucidal formulations containing povidone-iodine
KR102434736B1 (ko) 2021-11-04 2022-08-23 (주)씨에스하이테크플러스 신재생에너지를 이용한 에너지자립형 냉난방 시스템 및 방법
KR102917044B1 (ko) * 2023-06-22 2026-01-23 주식회사 퍼슨헬스케어 세정용 포비돈요오드 조성물 및 그 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
SE7902893L (sv) * 1979-04-02 1980-10-03 Astra Chem Prod Ab Desinfektionsmedel
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4526751A (en) * 1983-12-09 1985-07-02 Gartner William J Germicidal solutions effective for solid surface disinfection
WO1989000044A1 (fr) * 1987-07-07 1989-01-12 Santen Pharmaceutical Co., Ltd. Larme artificielle
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
JPH0662417B2 (ja) * 1987-12-25 1994-08-17 参天製薬株式会社 抗アレルギー点眼液
US4939272A (en) * 1989-05-05 1990-07-03 Gaf Chemicals Corporation Water soluble complexes of polyvinylpyrrolidone, hydrogen chloride and iodine and process for making the same
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.

Also Published As

Publication number Publication date
EP0526695A1 (en) 1993-02-10
AU1942792A (en) 1994-01-13
DE69224416T2 (de) 1998-07-30
ATE163130T1 (de) 1998-02-15
DK0526695T3 (da) 1998-09-23
NO306379B1 (no) 1999-11-01
NO922793L (no) 1993-01-18
IL101079A0 (en) 1992-11-15
EG19995A (en) 1997-01-30
CA2062001A1 (en) 1993-01-17
NO922793D0 (no) 1992-07-15
FI114443B (fi) 2004-10-29
JP3531945B2 (ja) 2004-05-31
CA2062001C (en) 1999-03-02
US5126127A (en) 1992-06-30
KR930001914A (ko) 1993-02-22
IE920796A1 (en) 1993-01-27
IL101079A (en) 1997-01-10
DE69224416D1 (de) 1998-03-19
EP0526695B1 (en) 1998-02-11
FI922906A0 (fi) 1992-06-22
FI922906L (fi) 1993-01-17
AU646745B2 (en) 1994-03-03
KR100191873B1 (ko) 1999-06-15
ZA921365B (en) 1992-11-25
JPH0570356A (ja) 1993-03-23

Similar Documents

Publication Publication Date Title
ES2111581T3 (es) Disoluciones estabilizadas de pvp-i.
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
AR247326A1 (es) Una composicion hipotonica acuosa para lentes de contacto.
ES464476A1 (es) Procedimiento para la obtencion de lentes de contacto del tipo hidrogel
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
ES464477A1 (es) Procedimiento para la produccion de lentes de contacto de configuracion concava-convexa
FR2710265B1 (fr) Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
DE3382637D1 (de) Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
ES2071227T3 (es) Composicion para gotas para los ojos.
BG95330A (bg) Контрастни средства
NO920408D0 (no) Farmasoeytiske preparater inneholdende furanderivater
EP0349487A3 (en) Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2-phenoxyethyl)-ammonium bromide and methods of using the same
IT1226072B (it) Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale.
IT8468196A1 (it) Dispositivo osmotico e procedimento per l'erogazione di un agente benefico, particolarmente di un farmaco ad un ambiente d'uso.
EP0175490A3 (en) Contact lens treatment compositions and their uses
DK538683A (da) Antimykotisk middel i gelform til behandling af svampeinfektion i mundhulen og fremgangsmaade til dets fremstilling
MX173572B (es) Matriz de espuma activa artropodicidalmente, estable, soluble en agua y metodo para su preparacion
DK0686694T3 (da) Anvendelse af azoler som virucide midler i opløsninger af biologisk aktive proteiner
DK0780121T3 (da) Øjendråbepræparat, især til behandling af tørre øjne
GB1464333A (en) Hydrophilic contact lens storage solution
IT8822558A0 (it) Soluzione farmaceutica acquosa per uso oftalmico.
ES2087863T3 (es) Composicion limpiacristales.
ES2032305T3 (es) Combinaciones fungicidas de sustancias activas.
IT1254707B (it) Uso topico della calcitonima per la preparazione di medicamenti nella cataratta idiopatica senile e una composizione farmaceutica che la contiene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526695

Country of ref document: ES